Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/3118 stock hub

TPEX/3118 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TPEX/3118is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.1B
Taipei Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TPEX/3118
In the news

Latest news · TPEX/3118

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12P50 15.5P75 22.5
Trailing P/E14.2
P25 14.4P50 18P75 31.9
ROE13.1
P25 -16.2P50 0.3P75 9.8
ROIC17.9
P25 -11.7P50 -0.2P75 8.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TPEX/3118 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
239
Groups with data
11
Currency
TWD
Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Taiwan
Country code
TW
Employees
128
Employees Change
-4%
Employees Change Percent
-3.03
Enterprise value
TWD 881.5M
Exchange
Taipei Exchange
Financial currency
TWD
First seen
2026-05-10
Industry
Biotechnology
Isin
TW0003118006
Last refreshed
2026-05-10
Market cap
TWD 1.1B
Price
TWD 33.8
Price currency
TWD
Rev Per Employee
5,613,890.63x
Sector
Healthcare
Sic
5047
Symbol
tpex/3118
Website
https://www.level.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
7.03%
EV Earnings
11.43x
EV/EBIT
9.87x
EV/EBITDA
7.97x
EV/FCF
26.31x
EV/Sales
1.23x
FCF yield
3.05%
P/B ratio
1.84x
P/E ratio
14.22x
P/S ratio
1.53x
PE Ratio10 Y
16.82x
PE Ratio3 Y
15.7x
PE Ratio5 Y
15.24x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

26
MetricValue
EBIT Margin
12.43%
EBITDA Margin
14.81%
FCF margin
4.66%
Gross margin
36.47%
Gross Profit
TWD 262.1M
Gross Profit Growth
8.67%
Gross Profit Growth Q
0.43%
Gross Profit Growth3 Y
8.35%
Gross Profit Growth5 Y
4.01%
Net Income
TWD 77.1M
Net Income Growth
22.97%
Net Income Growth Q
-5.55%
Net Income Growth Years
3%
Net Income Growth3 Y
10.88%
Net Income Growth5 Y
6.55%
Pretax Margin
13.36%
Profit Margin
10.74%
Profit Per Employee
TWD 602,727
Profitable Years
22
ROA
6.73
Roa5y
5.69
ROCE
14.67
ROE
13.11
Roe5y
12.13
ROIC
17.89
Roic5y
43.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

26
MetricValue
Cagr10y
4.67%
Cagr15y
3.2%
Cagr1y
11.54%
Cagr20y
10.33%
Cagr3y
6.77%
Cagr5y
7.24%
Div CAGR10
-1.05%
Div CAGR3
-1.79%
Div CAGR5
6.72%
EPS Growth
22.61
EPS Growth Q
-6.55
EPS Growth Years
3
EPS Growth3 Y
10.88
EPS Growth5 Y
6.51
FCF Growth3 Y
-22.7%
FCF Growth5 Y
-19.7%
OCF Growth
-7%
OCF Growth Q
-37.69%
OCF Growth10 Y
-4.82%
OCF Growth3 Y
-2.88%
OCF Growth5 Y
-6.46%
Revenue Growth
0.72x
Revenue Growth Q
-8.16x
Revenue Growth Years
3x
Revenue Growth3 Y
7.49x
Revenue Growth5 Y
1.84x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
TWD 0.87
Assets
TWD 834.4M
Cash
TWD 223.3M
Current Assets
TWD 499.9M
Current Liabilities
TWD 274.7M
Debt
TWD 7.9M
Debt EBITDA
TWD 0.07
Debt Equity
TWD 0.01
Debt FCF
TWD 0.24
Equity
TWD 597.5M
Interest Coverage
488.2
Liabilities
TWD 236.9M
Long Term Assets
TWD 334.5M
Long Term Liabilities
TWD -37.7M
Net Cash
TWD 215.4M
Net Cash By Market Cap
TWD 19.63
Net Cash Growth
-15.72%
Net Debt EBITDA
TWD -2.02
Net Debt Equity
TWD -0.36
Net Debt FCF
TWD -6.43
Tangible Book Value
TWD 597.5M
Tangible Book Value Per Share
TWD 18.41
WACC
5.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.11
Inventory Turnover
4.64
Net Working Capital
TWD 30.5M
Quick ratio
1.56
Working Capital
TWD 249.1M
Working Capital Turnover
TWD 3.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.07%
Dividend Growth
5.88%
Dividend Growth Years
1%
Dividend per share
TWD 2.2
Dividend Years
21
Dividend Yield
6.51%
Ex Div Date
2025-06-12
Last Dividend
TWD 1.8
Payout Frequency
Annual
Payout Ratio
75.72%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
57.78%
1Y total return
11.53%
200-day SMA
33.17
3Y total return
21.73%
50-day SMA
33.43
50-day SMA vs 200-day SMA
50over200
5Y total return
41.8%
All Time High
70.95
All Time High Change
-52.36%
All Time High Date
2008-05-21
All Time Low
3.96
All Time Low Change
753.1%
All Time Low Date
2004-11-11
ATR
0.32
Beta
0.24
Beta1y
-0.01
Beta2y
0.16
Ch YTD
2.42
High
33.85
High52
34.7
High52 Date
2026-04-30
High52ch
-2.59%
Low
33.7
Low52
31.8
Low52 Date
2025-07-18
Low52ch
6.29%
Ma50ch
1.09%
Price vs 200-day SMA
1.9%
RSI
59.11
RSI Monthly
57.48
RSI Weekly
58.22
Sharpe ratio
0.67x
Sortino ratio
1.67
Total Return
6.44%
Tr YTD
2.42
Tr15y
60.38%
Tr1m
0.45%
Tr1w
0.9%
Tr3m
3.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
TWD 89.3M
Operating Income Growth
10.92
Operating Income Growth Q
-6.33
Operating Income Growth3 Y
8.78
Operating Income Growth5 Y
4.86
Operating margin
12.43

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
22,457,146%
Net Borrowing
-4,703,000
Shares Insiders
27.72%
Shares Out
32,452,860
Shares Qo Q
0.6%
Shares Yo Y
0.07%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

64
MetricValue
Adjusted FCF
TWD 33.5M
Average Volume
25,825.2x
Bv Per Share
18.41
CAPEX
TWD -30.4M
Ch10y
-6.89
Ch15y
-26.75
Ch1m
0.45
Ch1w
0.9
Ch1y
5.63
Ch20y
171.8
Ch3m
3.21
Ch3y
4
Ch5y
7.82
Ch6m
0.75
Change
0.3%
Change From Open
0
Close
33.7
Days Gap
0.3
Depreciation Amortization
16,881,000
Dollar Volume
1,038,640.2
Earnings Date
2026-05-13
EBIT
TWD 89.3M
EBITDA
TWD 106.4M
EPS
TWD 2.38
F Score
5
FCF
TWD 33.5M
FCF EV Yield
3.8x
FCF Per Share
TWD 1.03
Financing CF
-63,282,000
Fiscal Year End
December
Founded
1,989
Graham Number
31.38045
Graham Upside
-7.16
Income Tax
TWD 18.9M
Investing CF
-34,639,000
Is Primary Listing
1
Last Earnings Date
2025-11-07
Last Report Date
2025-12-31
Last Split Date
2011-08-05
Last Split Type
Forward
Lynch Fair Value
TWD 15.56
Lynch Upside
-53.95
Ma150
33.37
Ma150ch
1.3%
Ma20
33.58
Ma20ch
0.67%
Net CF
-34,024,000
Next Earnings Date
2026-05-13
Open
33.8
P FCF Ratio
32.74
P OCF Ratio
17.17
Payment Date
2025-07-04
Position In Range
66.67
Ppne
323,521,000
Price Date
2026-05-08
Price EBITDA
TWD 10.31
Ptbv Ratio
1.84
Relative Volume
1.21x
Revenue
718,578,000x
Tax By Revenue
2.63x
Tax Rate
19.65%
Tr20y
613.94%
Tr6m
0.75%
Volume
30,729
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

TPEX/3118 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+6.5%
$2.20 annual per share
Payout ratio
+75.7%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+6.7%
1 consecutive years of growth
Total shareholder yield
+6.4%
Next ex-dividend date: 2025-06-12
Performance

TPEX/3118 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+11.5%
S&P 500 1Y: n/a
3Y total return
+21.7%
S&P 500 3Y: n/a
5Y total return
+41.8%
S&P 500 5Y: n/a
10Y total return
+57.8%
S&P 500 10Y: n/a
Ownership

Who owns TPEX/3118?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+27.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.1%
Negative means the company is buying back shares.
Technical

TPEX/3118 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
59.1
Neutral momentum band
Price vs 200-day MA
+1.9%
50/200-day relationship not available
Beta (5Y)
0.24
Less volatile than the market
Sharpe ratio
0.67
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TPEX/3118

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/3118 stock rating?

tpex/3118 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/3118 analysis?

The full report lives at /stocks/tpex/3118/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/3118?

The latest report frames tpex/3118 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/3118 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

tpex/3118 stock profile: metrics, valuation and analysis | Agente de Mercado de Ações com IA